Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
39.29 USD +6.19% Intraday chart for Spyre Therapeutics, Inc. +14.75% +82.57%
05-13 Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating MT
05-09 Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. News Spyre Therapeutics, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW